Breast Neoplasms: all 12,820 studies
Page 122 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Neoadjuvant TaxotereCompletedNCT00206505Phase 2
- Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer PatientsTerminatedNCT00206492Phase 2
- Biologic Correlative Taxotere/ACCompletedNCT00206466Phase 2
- Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast CancerTerminatedNCT00206453Phase 2
- Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast CancerTerminatedNCT00206414Phase 2
- XELOX for Metastatic Breast CancerCompletedNCT00204776Phase 2
- Neoadjuvant TAC Plus or Minus Bevacizumab(AVF3299)CompletedNCT00203372Phase 2
- Effects of Zometa and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast CancerCompletedNCT00202059Phase 3
- Predictors of Lymphedema Following Breast Cancer SurgeryCompletedNCT00202046
- PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)CompletedNCT00201942Phase 3
- A Decision Aid for Women With Early Stage Breast CancerCompletedNCT00201929Phase 3
- Trial of Decongestive Lymphatic Therapy for Lymphedema in Women With Breast Cancer "DELTA STUDY"CompletedNCT00201890Phase 3
- Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast CancerCompletedNCT00201708Phase 2
- Choline Quantification in Breast Cancer by MRSWithdrawnNCT00201487
- Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BCCompletedNCT00201435Phase 2/3
- Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone HealthCompletedNCT00200824Phase 2
- Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of DiseaseCompletedNCT00200174Not applicable
- PS-341 in Combination With Herceptin in Advanced Breast Cancer That Overexpresses HER-2CompletedNCT00199212Phase 1
- Venlafaxine for Hot Flashes After Breast CancerCompletedNCT00198250Phase 2
- Genomic & Proteomic Analysis of Docetaxel & Capecitabine as Primary Chemo for Stage II-III Breast CancerCompletedNCT00198237Phase 2
- Dendritic Cell Based Therapy of Metastatic Breast CancerTerminatedNCT00197925Phase 1/2
- Administration of Autologous Dendritic Cells (DCs) Infected With an Adenovirus Expressing Her-2CompletedNCT00197522Phase 1
- A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN)CompletedNCT00196872Phase 3
- Study in Elderly Patients With Early Breast Cancer (ICE)CompletedNCT00196859Phase 3
- Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO)CompletedNCT00196846Phase 2
- Mono Efficacy of Capecitabine (MoniCa)CompletedNCT00196820Phase 2
- Infrared Imaging (Breast Scan IR) for Early Breast Cancer DetectionCompletedNCT00195026
- Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast CancerCompletedNCT00194766Phase 2
- Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12CompletedNCT00194753Phase 2
- Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast CancerCompletedNCT00194740Phase 2
- Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast CancerCompletedNCT00194727Phase 2
- Enhancing Connections: Helping the Mother With Breast Cancer Support Her ChildCompletedNCT00194571Phase 3
- Assessing Impact of Loco-regional Treatment on Survival in Metastatic Breast Cancer at PresentationCompletedNCT00193778Not applicable
- Estrogen Priming to Increase the Efficacy of Adjuvant Chemotherapy in Operable Breast CancerTerminatedNCT00193726Phase 3
- Docetaxel Followed by Doxorubicin Plus Cyclophosphamide for Node Positive or High-Risk Primary Breast CancerCompletedNCT00193115Phase 2
- Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast CancerTerminatedNCT00193102Phase 2
- Docetaxel, Vinorelbine and Trastuzumab in the Treatment of Patients With Metastatic Her-2 Positive Breast CancerCompletedNCT00193089Phase 2
- Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast CancerCompletedNCT00193076Phase 2
- Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast CancerTerminatedNCT00193024Phase 2
- Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast CancerCompletedNCT00193011Phase 3
- Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines and/or TaxanesCompletedNCT00192101Phase 2
- A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast CancerCompletedNCT00192062Phase 2
- A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast CancerCompletedNCT00191672Phase 2
- Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic AgentsCompletedNCT00191438Phase 3
- A Trial for HER2 Positive Breast Cancer Patients With Metastatic DiseaseCompletedNCT00191373Phase 2
- A Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast CancerCompletedNCT00191347Phase 2
- Docetaxel vs. Docetaxel-Gemcitabine in Breast CancerCompletedNCT00191243Phase 2
- Raloxifene Use for The HeartCompletedNCT00190593Phase 3
- A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast CancerCompletedNCT00190489Phase 3
- Randomized Phase II Trial of Dose Dense Docetaxel in N+ Breast CancerCompletedNCT00189670Phase 2
- 6 FEC 100 Vs 4 FEC 100 Followed by 4 Taxol in N+ Breast CancerStatus unknownNCT00189644Phase 3
- UFT/LV Maintenance Vs Observation in Metastatic Breast Cancer Responsive to ChemotherapyStatus unknownNCT00189631Phase 3
- Breast Study Investigating a New Light Technique to Monitor Changes in Breast Tissue DensityCompletedNCT00188760
- Breast Study to Learn More About the Application of Optical Transillumination Measurements to Assess Breast Cancer Risk and to Potentially Detect the Presence of Breast Cancer.CompletedNCT00188721
- Breast Study to Determine the Ability of Non-Invasive Optical Transillumination Spectroscopy to Predict Breast Density.CompletedNCT00188682
- The Use of Pentoxifylline and Vitamin E in the Treatment of Chronic Breast PainTerminatedNCT00188669Phase 2
- The Use of Selenium to Treat Secondary Lymphedema - Breast CancerCompletedNCT00188604Phase 2
- Light Based Analysis of Developing Breast Tissue in Adolescent Girls: a Feasibility StudyCompletedNCT00188591
- A Clinical Trial to Reduce Skin Burn Induced by Breast Radiotherapy Using Intensity Modulated Radiation Therapy (IMRT)CompletedNCT00187343Phase 3
- CD34 Selection of the Peripheral Blood Stem Cell Graft for Autologous TransplantCompletedNCT00186680Phase 1/2
- Does a Peer Navigator Improve Quality of Life at Diagnosis for Women With Breast Cancer?CompletedNCT00186602
- Do Community Cancer Support Groups Reduce Physiological Stress in Women With Primary Breast Cancer?CompletedNCT00186524Phase 2
- Scintigraphic Assessment of I- Transport in Metastatic Breast Cancer and Evaluation of I31I Ablative Therapy: (Part I) Radioiodide Imaging StudyCompletedNCT00185809
- Accelerated Partial Breast Irradiation Following Lumpectomy for Breast CancerActive, not recruitingNCT00185744Not applicable
- Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.WithdrawnNCT00184288
- Characterization of Brain MetastasesCompletedNCT00184275
- Magnetic Resonance (MR) Spectroscopy of Breast Cancer TissueTerminatedNCT00184210
- Study of Fine Art Photographs and Visualization Tapes to Improve Surgical Recovery in Breast CancerTerminatedNCT00179634Not applicable
- Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With CancerCompletedNCT00179348Not applicable
- Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian CancersStatus unknownNCT00178802Phase 2
- Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility StudyCompletedNCT00176046Phase 4
- Does Scar Massage Improve Postoperative Pain and Function in Women With Breast Cancer?CompletedNCT00175344Phase 3
- Study of Docetaxel in Breast Cancer PatientsCompletedNCT00174707Phase 3
- BIG 02/98 Docetaxel - Breast CancerCompletedNCT00174655Phase 3
- Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast CancerCompletedNCT00174434Phase 1
- Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer PatientsCompletedNCT00174343Phase 2
- The Diagnostic Efficacy of Computer-Aided Detection (CAD) in Full-Field Digital Mammography (FFDM)- A Prospective StudyStatus unknownNCT00173303
- Zoledronic Acid in the Treatment of Breast Cancer With Minimal Residual Disease in the Bone MarrowTerminatedNCT00172068Phase 2
- Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic AcidCompletedNCT00172029Phase 4
- Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast CancerTerminatedNCT00171847Phase 4
- Reducing Arm Morbidity in Pre- and Post-breast Cancer SurgeryCompletedNCT00170235Not applicable
- Rollover Study Of Lapatinib In Cancer PatientsCompletedNCT00169533Phase 1
- Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat CancersCompletedNCT00169000Phase 1
- The Study of Infrared Imaging on Breast CancerStatus unknownNCT00166998
- Three Doses of TAS-108 to Treat Recurrent or Recurrent Inoperable Breast CancerCompletedNCT00166543Phase 2
- An Open-label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With CapecitabineTerminatedNCT00165880Phase 2
- High Dose Rate Intracavitary Brachytherapy as the Sole Method of Radiation Therapy for Breast CarcinomaTerminatedNCT00165581Not applicable
- Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease SurvivorsCompletedNCT00165308Not applicable
- Tangential Radiation Therapy Without Axillary Dissection in Breast CancerCompletedNCT00165243Phase 2
- Her-2/Neu in Patients With Metastatic Breast Cancer (AdHERe)CompletedNCT00162929Phase 1
- Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of EpirubicinTerminatedNCT00162812Phase 2
- Open Label Trial for Post-Menopausal Women With Newly Diagnosed Operable Breast CancerCompletedNCT00161291Phase 2
- Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast CancerCompletedNCT00161265
- Complementary Therapies for the Reduction of Side Effects During Chemotherapy for Breast CancerCompletedNCT00160901Phase 4
- Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast CancerTerminatedNCT00159458Phase 2
- A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast CancerStatus unknownNCT00159094Phase 2
- Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer.CompletedNCT00156806Phase 3
- Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and CapecitabineCompletedNCT00156312Not applicable
- Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast CancerCompletedNCT00156273
- Feasibility Study of Evaluating Breast Cancer Patients With Ductal LavageTerminatedNCT00156260